
BW LPG Successfully Closes Two Key Financing Facilities
The USD380 million Term Loan and Revolving Credit Facility, secured at a highly competitive margin, was supported by seven of our banking partners, with its proceeds used to finance vessels acquired from Avance Gas which was completed at the end of 2024. With the closing of this facility, BW LPG terminated its shareholder loan of USD250 million in June 2025 ahead of its expiry.
In parallel, BW LPG India has secured a USD215 million Term Loan Facility to refinance its existing debt and to support the acquisition of two modern VLGCs, BW Chinook and BW Pampero, from BW LPG as previously announced. This facility supports BW LPG India's continuous fleet renewal plan amid the sustained growth of India's LPG demand. BW LPG India, a subsidiary participated by Maas Capital Shipping and Global United Shipping, currently owns and operates India's largest fleet of VLGCs. Following the acquisition of these two VLGCs, BW LPG India will own nine VLGCs.
The USD215 million Term Loan was finalised with a significantly improved margin compared to the previous facility. It received strong backing from our five banking partners lending through their branches in Gujarat International Finance Tec-City (GIFT), India, enabling an overall financing costs reduction including benefit from withholding tax exemptions on interest payments.
'We are pleased to have successfully closed these key financing arrangements with enhanced terms and strong participation from both new and existing bank partners,' says Kristian Sorensen, CEO of BW LPG. 'This reaffirms the robust and ongoing support of our global banking network, and enhances our liquidity through dynamic markets ahead of us. We extend sincere gratitude to our partner banks across both facilities for their unwavering support to BW LPG.'
The facilities drew support across ten banks including Citibank N.A., DBS Bank Ltd., Development Bank of Japan Inc., DNB Bank ASA, ING, Mizuho Bank, Ltd., MUFG Bank, Ltd., OCBC, Skandinaviska Enskilda Banken AB (publ) and Standard Chartered.
About BW LPG
BW LPG is the world's leading owner and operator of LPG vessels, owning and operating a fleet of more than 50 Very Large Gas Carriers (VLGCs) with a total carrying capacity of over 4 million CBM. With five decades of operating experience in LPG shipping, an in-house LPG trading division and investment in LPG downstream distribution, BW LPG offers an integrated, flexible and reliable service to customers along the LPG value chain. Delivering energy for a better world – more information about BW LPG can be found at https://www.bwlpg.com.
BW LPG is associated with BW Group, a leading global maritime company involved in shipping, floating infrastructure, deepwater oil & gas production, and new sustainable technologies. Founded in 1955 by Sir YK Pao, BW controls a fleet of over 450 vessels transporting oil, gas and dry commodities, with its 200 LNG and LPG ships constituting the largest gas fleet in the world. In the renewables space, the group has investments in solar, wind, batteries, and water treatment.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
General Motors Q2 Earnings Preview: What to Expect From Upcoming Report
July 21 - General Motors (NYSE:GM) will report second?quarter results Tomorrow, July 22 Analysts expect adjusted earnings per share of $2.32, down about 24 percent year?on?year, on revenue of $45.79 billion, roughly a 5 percent decline from the prior period. Warning! GuruFocus has detected 3 Warning Sign with GM. On July 2, GM said U.S. sales rose 7.3 percent to 746,588 vehicles in the quarter, driven by strong demand for crossovers and full?size pickups. Electric vehicle deliveries also saw an uptick, though they remain constrained by competition and shifting U.S. incentive policies. Last month, the automaker outlined plans to invest up to $4 billion over two years to expand capacity at plants in Michigan, Kansas and Tennessee, aiming to bolster production of both gas?powered and electric models. Goldman Sachs analyst Mark Delaney maintained a Buy rating and raised his price target to $70, noting that milder-than?expected tariffs could support U.S. auto sales. He still sees sales easing in the second half, forecasting 15.75 million units in 2025 and 15.50 million in 2026. Options traders are bracing for a potential share move of about 5.9 percent in either direction after the earnings release. Is GM Stock a Buy? Based on the one year price targets offered by 27 analysts, the average target price for General Motors Co is $54.82 with a high estimate of $83.00 and a low estimate of $34.00. The average target implies a upside of +3.01% from the current price of $53.22. Based on GuruFocus estimates, the estimated GF Value for General Motors Co in one year is $60.28, suggesting a upside of +13.27% from the current price of $53.22. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Helios Technologies Schedules Second Quarter 2025 Financial Results Release and Conference Call
SARASOTA, Fla., July 21, 2025--(BUSINESS WIRE)--Helios Technologies (NYSE: HLIO) ("Helios" or the "Company"), a global leader in highly engineered motion control and electronic control technologies, announced today that it will release its second quarter 2025 financial results after the market closes on Monday, August 4, 2025. Sean Bagan, President, Chief Executive Officer and Chief Financial Officer, will host a conference call and webcast the next morning to review the Company's financial and operating results and discuss its outlook. Second Quarter 2025 Financial Results Conference Call: Tuesday, August 5, 20259:00 a.m. Eastern TimePhone: (201) 689-8573Internet webcast and accompanying slide presentation: A telephonic replay will be available from approximately 1:00 p.m. ET on the day of the call through Tuesday, August 19, 2025. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13754274. The webcast replay will be available in the investor relations section of the Company's website at where a transcript will also be posted once available. About Helios TechnologiesHelios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine and health and wellness. Helios sells its products to customers in over 90 countries around the world. Its strategy for growth is to be the leading provider in niche markets, with premier products and solutions through innovative product development and acquisitions. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information please visit: and follow us on LinkedIn. View source version on Contacts For more information, contact: Tania AlmondVice President, Investor Relations and Corporate Communication(941) Deborah PawlowskiAlliance Advisors LLC(716) 843-3908dpawlowski@ Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Bristol-Myers Squibb Company (BMY): All Or Nothing With A Breakthrough Drug, Says Jim Cramer
We recently published . Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently discussed. Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies. It has long been one of Cramer's favorite stocks as the CNBC TV host has been nothing but full of optimism about its COBENFY schizophrenia drug. However, during this show, he changed his tone and pinned all hopes on COBENFY's success: '[Report about the two selling Eliquis at a discount] Yeah, I mean, mistakes I've made a few but, today I'm looking at Bristol, Bristol better come through with this. With this mental health, with this mental health drug that they bought, the schizophrenic drug. . . .I mean Bristol is uh, Bristol's bad. And I own it. I own it because of this schizophrenia drug. And I said yesterday to the club, they get this schizophrenia drug, I'm going with it. They don't get this schizophrenia drug, I've never heard of it. That's where I am. Never heard of Bristol-Myers.' A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution. Previously, Cramer discussed Bristol-Myers Squibb Company (NYSE:BMY)'s 'faint pulse': 'Of course, some of the rally's nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something good to say about them. Maybe it's enough to say that Bristol Myers has a faint pulse, one that lasted until the end of the session.' While we acknowledge the potential of BMY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.